Goldman Sachs bets €145M on a longevity resort in Marbella

Ilanga Capital, the investment group chaired by Pelayo Cortina Koplowit, and Goldman Sachs Alternatives have signed a €145M senior financing deal for Oakmond, a longevity and wellness resort in Marbella. The project now moves into its main development phase with an asset and capital base north of €400M, and the opening is pencilled in for Q3 2029.

The money tells you where this is heading. Longevity is no longer a niche spa-add-on, it's a full asset class with structured debt behind it. For hoteliers reading this, the interesting part isn't the headline figure, it's the signal: capital is willing to underwrite wellness as the core of a resort, not a tired amenity bolted onto the gym floor.

My read: anyone running a wellness or medical-tourism property in Southern Europe should be looking hard at how Oakmond builds its guest journey, from diagnostics to programming to repeat stays. A €400M+ benchmark raises the bar for what premium wellness tech (biomarkers, personalisation, CRM tied to health data) needs to look like. The opportunity here is obvious for the segment around it.